Pharma & Biotech

Despite posting impressive double-digit revenue growth and receiving votes of confidence from its leadership, Redcare Pharmacy's stock continues its relentless...

BioNxt Solutions has achieved a pivotal regulatory milestone that could fundamentally reshape its long-term commercial prospects. The biotechnology firm has...

Despite recent market jitters affecting investor sentiment, the underlying financial performance of French vaccine specialist Valneva tells a different story....

BioAtla Inc has successfully secured fresh capital, but the terms of the financing have raised significant questions about the company's...

Castle Biosciences, a prominent player in the diagnostic sector, is witnessing a remarkable surge in its stock value, with shares...

After experiencing significant pressure earlier this year, biotechnology firm Xencor is demonstrating a notable resurgence. The company's equity has advanced...

Speculative investors in InnoCan Pharma received the news they've been anticipating, with groundbreaking research data potentially paving the way for...

Amicus Therapeutics has achieved a significant financial turning point, reporting its first GAAP-profitability alongside substantial revenue growth. The biotechnology firm's...

The competitive landscape for anti-obesity medications has been jolted by a significant development from Viking Therapeutics. The biopharmaceutical company announced...

The Danish pharmaceutical giant, once Europe's most valuable company, now faces a critical inflection point. In a dramatic strategic pivot,...